Introduction {#Sec1}
============

Hydrogen peroxide (H~2~O~2~) is produced by every cell in the body and has an important physiological role in cellular processes such as membrane signal transduction, gene expression, cell differentiation, insulin metabolism, cell shape determination and growth factor induced signaling cascades (Di Marzo et al. [@CR21]; Lennicke et al. [@CR58]; Sies [@CR99]). However, when produced in excess, cellular H~2~O~2~ has been implicated in the development of disease.

A causal role for H~2~O~2~ in the pathogenesis of ulcerative colitis has been proposed (Pravda [@CR79]). This is supported by significantly elevated colonic mucosal H~2~O~2~ (a known colitic agent) reported prior to the appearance of colonic inflammation in patients with ulcerative colitis (UC) (Santhanam et al. [@CR94]; Meyer et al. [@CR64]; Sheenan and Brynjolfsson [@CR97]). Cumulative evidence also supports a causal role for H~2~O~2~ in the development of sepsis (Pravda [@CR80]). And toxic levels of blood H~2~O~2~ been documented in patients with sepsis (van Asbeck et al. [@CR112]). H~2~O~2~ toxicity can result in laboratory and clinical abnormalities observed in sepsis, including immunosuppression, bioenergetic organ failure and hypotension among others (Pravda [@CR80]; Shenep et al. [@CR98]). Cumulative evidence likewise supports a causal role for H~2~O~2~ (a potent apoptotic agent) in the amplified lymphocyte and macrophage apoptosis observed in systemic lupus erythematosus (SLE) (Pravda [@CR81]). Excessive lymphocyte and macrophage apoptosis can lead to enhanced auto-antigenic exposure and chronic auto-immune activation, which is characteristic of SLE (Pravda [@CR81]). The variety of disease patho-phenotypes exhibited by H~2~O~2~ is made possible by its distinct properties and the target cell/tissue type in which H~2~O~2~ accumulates. Target sites vary from a cellular level in SLE (lymphocytes/macrophage) to a tissue level in UC (colonic epithelium) or systemically in sepsis (Fig. [1](#Fig1){ref-type="fig"}). The next section presents the evidence supporting a common causal role for H~2~O~2~ in the in the above three diseases. Fig. 1Hydrogen peroxide and disease: A unified mechanism of pathogenesis. Environmental oxidative stress (infections, stress, xenobiotics etc.) leads to increased cellular hydrogen peroxide (H~2~O~2~). Significantly elevated levels of H~2~O~2~ have been documented in the colonic mucosa of patients with ulcerative colitis prior to the appearance of colitis, and toxic levels of H~2~O~2~ have been reported in blood of patients with sepsis. Cumulative evidence also supports a casual role for excess lymphocyte and macrophage H~2~O~2~ in the pathogenesis of systemic lupus erythematosus. H~2~O~2~ has distinct properties that can lead to the development of each disease. They are: **1**) increased by environmental oxidative stress exposure; **2**) Potent apoptotic agent; **3**) Impairment of phagocytosis; **4**) Biomembrane permeability; **5**) Chemotactic for neutrophils; **6**) Oxidant induced intestinal barrier disruption; **7**) Enzyme inhibition and **8**) Hypotensive agent (Pravda [@CR79]; Shenep et al. [@CR98]; Pravda [@CR81]; Redza-Dutordoir and Averill-Bates [@CR88]; Xiang et al. [@CR118]; Oosting et al. [@CR74]; Möller et al. [@CR66]; Klyubin et al. [@CR55]; Rao et al. [@CR87]; Tatsumi and Kako [@CR101]; Tretter and Adam-Vizi [@CR105]) The resulting disease phenotype is a function of one or more properties of H~2~O~2~ and the target cell in which H~2~O~2~ accumulate; i.e., lymphocytes and macrophages in SLE, colonic epithelium in ulcerative colitis and systemic accumulation in sepsis. The capacity of cellular H~2~O~2~ to increase in response to environmental oxidative stressors is critical to disease development. Determination of specific cell target and subsequent disease phenotype is dependent upon environmental oxidant stress exposure and differential tissue reductive (H~2~O~2~ neutralizing) capacity influenced by genetic or epigenetic predisposition

H~2~O~2~ - A common causal role {#Sec2}
===============================

Ulcerative colitis {#Sec3}
------------------

Ulcerative colitis is a major form of inflammatory bowel disease that strikes in the prime of life, mainly in late adolescence to early adulthood (Magro et al. [@CR61]). The rising worldwide incidence of UC has made it a global disease affecting nearly a million Americans (Ng et al. [@CR69]). Ulcerative colitis follows a chronic relapsing and remitting course characterized by abdominal pain, bloody diarrhea, urgency and tenesmus, all of which are related to inflammation of the large intestine (Tripathi and Feuerstein [@CR108]). An immune abnormality is the generally accepted mechanism thought to cause this condition despite extensive research conducted since the mid-twentieth century having failed to establish a primary antecedent immune abnormality in individuals with UC or their family members. (Kirsner [@CR53]; Kirsner [@CR54]). However, significantly elevated levels of H~2~O~2~ have been documented in the colonic epithelium prior to the appearance of inflammation in individuals with UC suggesting a causal role in the development of this disease (Santhanam et al. [@CR94]).

Excess H~2~O~2~ produced by colonocytes (colonic epithelial cells) can easily diffuse through the cell membrane to the extracellular space. H~2~O~2~'s unique properties of cell membrane permeability, long life, potent oxidizing potential and neutrophilic chemotactic ability combine to promote oxidative disintegration of colonic epithelial tight junctional proteins while attracting white blood cells into the colonic epithelium, both of which lead to colonic inflammation and eventual ulcerative colitis (Pravda [@CR82]). Supporting this interpretation are studies reporting the development of ulcerative colitis in animals and humans after colonic installation of H~2~O~2~ (Meyer et al. [@CR64]; Sheenan and Brynjolfsson [@CR97]). Colonic inflammation analogous to human ulcerative colitis is also reported in glutathione peroxidase knockout mice that are unable to neutralize H~2~O~2~ resulting in colonocyte accumulation of H~2~O~2~ and colitis (Esworthy et al. [@CR25]).

Hydrogen peroxide is produced by several sub-cellular structures whose production of H~2~O~2~ can be increased by environmental factors (called oxidative stressors). The cumulative effect of environmental oxidative stressors can lead to the buildup of colonocyte H~2~O~2~ and eventual UC. For example, serotonin is an enteric neurotransmitter that is normally released by colonic mucosal enterochromaffin cells in order to stimulate enteric nerve terminals to initiate a colonic peristaltic wave (Beattie and Smith [@CR7]). However stress, a known risk factor for UC relapse, can significantly increase colonic contractility (spasm) with the release of significantly greater amounts of serotonin (Bitton et al. [@CR11]; Grace [@CR37]; Almy et al. [@CR2]). The excess serotonin is taken up by colonocytes and metabolized by mono-amine oxidase (EC\#1.4.3.4) to H~2~O~2~ (Sturza et al. [@CR100]). Thus, acute severe or prolonged stress can lead to excess colonocyte serotonin metabolism accompanied by H~2~O~2~ accumulation, which can overwhelm colonocyte reductive capacity and contribute to UC relapse. In this regard, studies have shown that serotonin has a critical role in the pathogenesis of experimental colitis (Ghia et al. [@CR36]).

Other risk factors for UC also increase cellular H~2~O~2~. These include high fat diets that contribute to cellular H~2~O~2~ load via peroxisomal beta-oxidation of long-chain fatty acids, which generates large amounts of H~2~O~2~ (Hou et al. [@CR46]; Lismont et al. [@CR59]; Elsner et al. [@CR23]; Antonenkov et al. [@CR3]). Alcohol also contributes to cellular H2O2 accumulation due to cytochrome oxidase CYP2E1 metabolism, which generates H~2~O~2~ (Hoek et al. [@CR42]). Alcohol also inhibits active transport of glutathione into mitochondria where it is needed to neutralize H~2~O~2~ generated by the electron transport chain thus facilitating mitochondrial build-up of H2O2 (Maher [@CR62]; Fernandez-Checa et al. [@CR29]). Studies have shown that high alcohol intake triples the risk of UC relapse (Jowett et al. [@CR50]). Environmental xenobiotic contaminants such as mercury are severe oxidative stressors that increase cellular H~2~O~2~ by inactivation of thiols such as glutathione, which is critical for H~2~O~2~ elimination (Jan et al. [@CR47]; Rubino [@CR92]). Inhalation of minute amounts of mercury vapor can initiate rectal bleeding and relapse of UC (Cummings and Rosenman [@CR20]).

Cigarette smoking cessation is a powerful risk factor for the development of UC (Sands and Compton [@CR93]; Odes et al. [@CR72]; Pryorham et al. [@CR86]). Tobacco smoking cessation can trigger UC by removing the reported 82% electron transport chain (ETC) inhibition caused by chemicals in tobacco (Pryor et al. [@CR85]). This allows increased ETC metabolism of reducing equivalents (NADH, FADH2) that generates additional H~2~O~2~. Finally, markedly elevated levels of tissue homocysteine have been reported in colonic mucosa of individuals with UC and a meta-analysis found that serum homocysteine levels were significantly higher in UC groups compared to healthy controls (*P* \< 0.001) (Morgenstern et al. [@CR67]; Zhong et al. [@CR121]). Homocysteine is a potent oxidative stressor that increases H~2~O~2~ in several ways. H~2~O~2~ is generated during the oxidation of homocysteine to homocystine, and homocysteine increases levels of superoxide dismutase, which converts superoxide to H~2~O~2~ (Friedman et al. [@CR32]; Upchurch Jr et al. [@CR110]; Wilcken et al. [@CR116]). Homocysteine inhibits glutathione peroxidase (GPx) (a critical H~2~O~2~ neutralizing enzyme) activity by 10-fold, and inhibition of GPx was shown to occur at physiologic (9 μmol/L) concentrations of free homocysteine (Upchurch Jr et al. [@CR110]; Chen et al. [@CR19]). Thus, the cumulative effect of endogenous and exogenous H~2~O~2~ inducing environmental oxidative stressors originating from different sources can contribute to colonocyte build-up of H~2~O~2~ and UC.

Perhaps the most perplexing observation regarding the natural history of ulcerative colitis is why the inflammation almost always begins in the rectum? This can now be easily explained with data from studies showing that reductive capacity progressively decreases from proximal to distal areas of the large intestine, with rectal epithelial cells having the least protection against the buildup of H~2~O~2~ (Hoensch et al. [@CR43]). This causes the rectum to be the first location in the large intestine where H~2~O~2~ will accumulate and cause inflammation after exposure to oxidative stress in individuals with ulcerative colitis.

Based on this new pathogenesis of UC, a novel therapy was designed whose goal was focused on the restoration of colonic redox homeostasis by reducing colonic epithelial hydrogen peroxide, which the data implied was the upstream cause of the inflammation. The therapy was offered to patients with refractory ulcerative colitis over a several-year period and the results published as a case report. In 36 patients with moderate to severe refractory disease, histologic remission (complete mucosal healing) was achieved by 85% in an average of 54 days (Pravda et al. [@CR83]).

Sepsis {#Sec4}
------

Sepsis is a life-threatening condition that is defined as the body's extreme response to an infection, which can result in multi-organ failure and fatal hemodynamic shock (Centers for Disease Control [@CR17]). The exact nature of the body's response leading to sepsis remains unknown. However, cytotoxic levels of blood hydrogen peroxide of over 18x the accepted upper limit of normal have been documented in the blood of individuals with sepsis and septic shock (van Asbeck et al. [@CR112]). Blood H~2~O~2~ is normally between 1 and 5 μM (close to zero) with an accepted upper limit of 30 μM above which general cytotoxicity begins to set in (Forman et al. [@CR30]). However, values up to 558 μM have been documented in the blood of patients with sepsis and septic shock (van Asbeck et al. [@CR112]).

Hypermetabolism is a hallmark of critical illness such as sepsis and nearly all the fuel utilized to power the increased metabolic activity is supplied by ATP. Most cellular ATP is generated via oxidative phosphorylation which produces H~2~O~2~ as a by-product of electron transport chain (ETC) activity. Under normal conditions H~2~O~2~ is efficiently neutralized however, the abrupt global increase of cellular bioenergetic reactions to several times their normal basal state presents the cell with a large surge of hydrogen peroxide that must be eliminated to avoid accumulation and cell death. Prolonged supraphysiological production of hydrogen peroxide generated by ETC hyperactivity during a hypermetabolic state can overwhelm cellular reductive (antioxidant) systems leading to H~2~O~2~ accumulation within tissues and blood. Hydrogen peroxide is a highly toxic membrane-permeable metabolic poison that can cause severe bioenergetic dysfunction and cellular damage if allowed to accumulate. Continued exposure can lead to the collapse of redox homeostasis, organ failure, microvascular dysfunction and fatal septic shock, as discussed below.

Significant depletion of cellular glutathione (principal H~2~O~2~ reducing agent) in lung and skeletal muscle suggests that these organs have become net H~2~O~2~ generators contributing to the rise of blood H~2~O~2~ in sepsis (Pacht et al. [@CR75]; Hammarqvist et al. [@CR39]). The increased systemic production of H~2~O~2~ is reflected in the depletion of whole blood reductive capacity (ability to remove H~2~O~2~) (Lyons et al. [@CR60]). Systemic depletion of reductive capacity portends a grave outcome as was demonstrated in a study that documented significantly decreased erythrocyte glutathione in sepsis non-survivors vs survivors (*P* \< 0.0001) (Karapetsa et al. [@CR51]). Furthermore, cellular exposure to H~2~O~2~ can result in metabolic dysfunction that enhances cellular production of H~2~O~2~ (Zorov et al. [@CR122]). This increases the overall H~2~O~2~ load creating a positive feedback loop (vicious cycle) that increases H~2~O~2~ accumulation in the body.

The systemic toxic effects of H~2~O~2~ mirror the laboratory and clinical abnormalities observed in sepsis such as hyperlactatemia. Sepsis associated hyperlactatemia is a strong independent predictor of mortality (Garcia-Alvarez et al. [@CR35]). H~2~O~2~ can increase cellular lactate by interrupting mitochondrial oxidative energy flux, which is needed to maintain the proton motive force that fuels pyruvate import into the mitochondrial matrix (Bender and Martinou [@CR9]).

H~2~O~2~ is reported to inhibit Krebs' cycle enzymes such as aconitase, alpha-ketoglutarate dehydrogenase and Succinate Dehydrogenase (Tretter and Adam-Vizi [@CR105]; Tretter and Adam-Vizi [@CR107]; Nulton-Persson and Szweda [@CR71]). Diminished Krebs cycle supplied reducing equivalents (NADH, FADH2) can collapse the mitochondrial proton gradient and impair the proton motive force needed for pyruvate translocase in the inner mitochondrial membrane to transport pyruvate into mitochondria in symport with a proton (Bender and Martinou [@CR9]). The end result is increased cytosolic pyruvate and subsequent conversion to lactate with resulting hyperlactatemia. The effect of a dysfunctional Krebs cycle on serum lactate level is observed in the inherited deficiency of alpha-ketoglutarate dehydrogenase, which is associated with severe congenital hyperlactatemia (Bonnefont et al. [@CR12]).

H~2~O~2~ is also reported to inhibit mitochondrial adenine nucleotide transporter and ATP synthase at exposures as low as 10 μM (Tatsumi and Kako [@CR101]). These enzymes are critical for the synthesis of ATP and their inhibition can lead to bioenergetic failure, which is observed in advanced sepsis (Japiassú et al. [@CR48]). In sepsis, lymphocytes are exposed to H~2~O~2~ concentrations of over 500X the 1 μM needed to induce apoptosis (van Asbeck et al. [@CR112]; Antunes and Cadenas [@CR4]). This results in a significant lymphocyte apoptosis (lymphocyte death) resulting in a marked lymphopenia affecting all lymphoid organs in the body including spleen, thymus, intestinal epithelium, lymph nodes and GI tract lymphoid tissue (Exline and Crouser [@CR27]; Hotchkiss et al. [@CR44]; Hotchkiss et al. [@CR45]; Tinsley et al. [@CR103]; Felmet et al. [@CR28]). Thus, H~2~O~2~ toxicity can account for the profound immunosuppression observed in sepsis.

Microangiopathic dysfunction and hypotension are common findings in advanced sepsis (Pravda [@CR81]). H~2~O~2~ toxicity results in microangiopathic dysfunction and studies have reported hypotension in an animal model after intravenous administration of H~2~O~2~ (Shenep et al. [@CR98]). Consistent with the known pathogenic effects of H~2~O~2~ is a report describing a fatal case of sepsis with multi-organ failure in a previously healthy 37-year-old man after receiving several intravenous infusions of H~2~O~2~ (Wetter and Davis [@CR115]).

Other clinical abnormalities observed in sepsis such as coagulopathy, encephalopathy, erythrocyte rigidity, glutathione depletion, cardiac dysfunction, methemoglobinemia, and mitochondrial dysfunction are also documented adverse effects of H~2~O~2~ (Pravda [@CR80]; Zanotti-Cavazzoni and Hollenberg [@CR120]; Ohashi et al. [@CR73]; Fredriksson et al. [@CR31]; Brealey et al. [@CR13]; Weiss [@CR114]; Evans et al. [@CR26]; Ballinger et al. [@CR6]) all of which contribute to multiple organ failure observed in sepsis.

In summary, a hypermetabolic bio-energetic state in response to a systemic insult will generate supra-physiologic amounts of H2O2 that can overwhelm systemic reductive (anti-oxidant) capacity leading to the accumulation of this toxic metabolic poison in tissues and blood resulting in multi-organ bioenergetic failure and micro-angiopathic dysfunction observed in sepsis.

The evidence-based specific treatment of sepsis is discussed below.

Systemic lupus erythematosus {#Sec5}
----------------------------

Systemic lupus erythematosus (SLE) is a chronic disease characterized by the production of autoreactive antibodies and cytokines that are thought to have a major role in disease activity and progression, which is marked by inflammation and multiple organ damage. The etiology and pathogenesis of SLE remain unknown (Rekvig [@CR89]). However, exposure of the adaptive immune system to intracellular auto-antigens is thought to be a principal mechanism that initiates chronic immune activation giving rise to auto-antibody and cytokine production.

Apoptosis is believed to play a significant role in pathological autoantigen presentation because of the sheer volume of cellular mass normally undergoing apoptosis amounting to 150 billion cells per day or over 10% of total cellular body mass per month (Pravda [@CR81]; Elliott and Ravichandran [@CR22]). If apoptosis of this large dying cell mass is allowed to proceed unchecked, it would continuously expose intracellular autoantigens to the adaptive immune system as dying apoptotic cells undergo secondary necrosis and intracellular autoantigenic contents are released into the extracellular environment or bloodstream where they would elicit an immune response (Pravda [@CR81]; Jorge and Means [@CR49]; Caruso and Poon [@CR16]). This does not normally happen because the adaptive immune system is mostly shielded from exposure to autoantigens by phagocytes (i.e. macrophages) that can identify cells undergoing apoptosis and target them for phagocytosis, which safely degrades autoantigens, preventing immune activation (Pravda [@CR81]; Arandjelovic and Ravichandran [@CR5]; Yoon [@CR119]; Munoz et al. [@CR68]).

However, in SLE apoptosis is increased and phagocytosis is contemporaneously impaired leading to enhanced and prolonged autoantigenic exposure (Yoon [@CR119]; Mistry and Kaplan [@CR65]; Herrmann et al. [@CR41]). In particular, enhanced lymphocyte apoptosis and impaired macrophage phagocytosis observed in patients with SLE are postulated to play a prominent role in the development of this condition (Pravda [@CR81]). Cumulative evidence supports a causal role for metabolically generated H~2~O~2~ during lymphocyte activation leading to enhanced lymphocyte apoptosis and subsequent auto-antigenic exposure resulting in chronic immune activation chacteristic of SLE (Pravda [@CR81]). H~2~O~2~ is a potent apoptotic agent and lymphocytes are highly sensitive to H~2~O~2~ induced apoptosis, which can occur at exposures of less than 1 μM (Redza-Dutordoir and Averill-Bates [@CR88]; Xiang et al. [@CR118]; Antunes and Cadenas [@CR4]).

A large amount of H~2~O~2~ is generated during lymphocyte activation as a result of acutely increased metabolic activity. Lymphocyte activation has been described as a metabolic "bomb" during which metabolic activity is greatly upregulated to provide the necessary energy in the form of ATP in order to fuel increased metabolic demands that occur during the clonal-expansion response to infection or receptor signal transduction (Buck et al. [@CR15]). The principal source of cellular hydrogen peroxide is mitochondrial electron transport chain auto-oxidation and associated metabolic enzymes (Wong et al. [@CR117]; Mailloux [@CR63]; Tretter and Adam-Vizi [@CR106]). Additional sources of cellular H~2~O~2~ can be found in the endoplasmic reticulum, peroxisomes, and cytosol (Belikov et al. [@CR8]). All of these H~2~O~2~ site generators contribute to the increased metabolic H~2~O~2~ load during lymphocyte activation.

If H~2~O~2~ generated during lymphocyte activation overwhelms the cell's reductive (antioxidant) capacity), the subsequent H~2~O~2~ buildup can trigger apoptosis. This interpretation is supported by studies reporting that enhanced apoptosis is associated with depleted glutathione in lymphocytes of patients with SLE, and depleted glutathione levels are significantly associated with worse disease in patients with SLE (*p* \< 0.006) (Shah et al. [@CR96]; Tewthanom [@CR102]). Because glutathione is the major reducing agent responsible for the neutralization of cellular H~2~O~2~, a reduction in cellular glutathione will result in elevated cellular H~2~O~2~, which can trigger apoptosis and worsening disease. Elevated H~2~O~2~ also causes impaired macrophage phagocytosis, which prevents elimination of apoptotic cells and enhances auto-sensitization (Oosting et al. [@CR74]).

With a self-repleting cell mass that is 5-fold greater than the liver (2 trillion lymphocytes/360 billion liver cells) (Alberts et al. [@CR1]; Bianconi et al. [@CR10]), lymphocytes are a significant and replenishing source of auto-antigenic exposure if widespread lymphocyte activation triggers H~2~O~2~-induced mass lymphocyte apoptosis. Widespread lymphocyte activation and clonal expansion can occur, for example, due to infection. Additionally, lymphocytes also express receptors for estrogen and adrenergic hormones, which can result in mass lymphocyte activation when lymphocytes are exposed to high concentrations of these hormones after female puberty or emotional stress respectively (Khan and Ansar [@CR52]; Kovats [@CR56]; Segerstrom and Miller [@CR95]; Viswanathan and Dhabhar [@CR113]). All three stimuli (infection, female gender and stress) are known SLE exacerbating factors.

Thus, a pathogenetic picture emerges in which lymphocyte activation and increased macrophage activity (phagocytosis) result in excess metabolically generated H~2~O~2~, which depletes cellular glutathione. This facilitates the intracellular build-up of H~2~O~2~ that triggers apoptosis and impaired phagocytosis in lymphocytes and macrophages respectively, both of which combine to cause repeated, enhanced and prolonged exposure of auto-antigens to the adaptive immune system leading to auto-antibody formation with hyper-cytokinemia and eventual SLE. Treatment of SLE patients with N-acetylcysteine to promote the synthesis of glutathione has been shown to reduce diseases activity, supporting a causal role for H~2~O~2~ in the pathogenesis of SLE (Lai et al. [@CR57]; Garcia et al. [@CR34]).

This data implies that SLE does not start out as an auto-immune disorder but becomes one as a result of continual H~2~O~2~ mediated lymphocyte apoptosis and impaired phagocytosis leading to chronic auto-antigenic exposure, adaptive immune system activation and subsequent development of SLE.

Treatment {#Sec6}
---------

In addition to supportive measures and antibiotic therapy (when indicated for infection), there is a need for effective therapeutic interventions to address the underlying causal process in each of these three diseases. Specifically, there is an urgent need for a specific treatment for sepsis, an often-fatal condition that has defied all attempts at therapeutic intervention. Based on the highly elevated blood hydrogen peroxide levels observed in sepsis patients and cumulative evidence supporting a causal role for this toxic metabolite in sepsis development, it is reasonable to expect that reduction of blood hydrogen peroxide will have a significant therapeutic impact in reducing sepsis mortality and the post-sepsis syndrome.

A therapeutic agent that can effectively neutralize hydrogen peroxide upon contact is sodium thiosulfate (STS). The general chemical reaction for the reduction of hydrogen peroxide with sodium thiosulfate yields sodium trithionate, sodium sulfate and water.

2 Na~2~S~2~O~3~ + 4 H~2~O~2~ → Na~2~S~3~O~6~ + Na~2~SO~4~ + 4H~2~O {#Sec7}
==================================================================

Depending on the relative concentration of reactants, other STS oxidation products are possible including sodium dithionate (Na~2~S2O6), sodium tetrathionate (Na2S4O6) and H~2~SO~4~ (sulfuric acid). STS is approved for use in cyanide poisoning with a recommended dose of 12.5 g over slow IV infusion (10 to 20 min) in adults and 250 mg/kg in children (US Department of Health and Human Services [@CR111]). Similar dosing regimens can be considered in sepsis. STS is accepted therapy for the treatment cisplatin toxicity (Tsang et al. [@CR109]), calciphylaxis due to chronic renal failure (Nigwekar et al. [@CR70]), and is reported to lower the incidence of cisplatin-induced ototoxic hearing loss in children with hepatoblastoma (Brock et al. [@CR14]). STS is generally well tolerated.

Because blood H~2~O~2~ is significantly elevated in sepsis, the bidirectionality of H~2~O~2~ cell-membrane permeability implies a similar H~2~O~2~ load within the intracellular compartment (van Asbeck et al. [@CR112]). Due to its significant reductive capacity derived from reduced thiols in serum albumin and erythrocyte glutathione, whole blood normally functions as a physiological redox sink for H~2~O~2~ diffusing from the intracellular compartment into the systemic circulation (Roche et al. [@CR91]; Cha and Kim [@CR18]; Tozzi-Ciancarelli et al. [@CR104]). Consequently, systemically elevated H~2~O~2~ indicates depletion of reductive capacity in whole blood and within the intracellular compartment (Lyons et al. [@CR60]).

Thus, the goal of treatment is to reduce blood H~2~O~2~ to normal (less than 30uM) to allow intracellular H~2~O~2~ to diffuse down its concentration gradient into the systemic circulation where it can be neutralized by STS. This suggests that repeat dosing of STS may be necessary as blood H~2~O~2~ is removed by STS, and intracellular H~2~O~2~ re-equilibrates with the intravascular compartment after initial treatment. STS is also reported to replenish intracellular glutathione, which will aid in removal of intracellular H~2~O~2~ and restoration of redox homeostasis (Enongene et al. [@CR24]; Hayden et al. [@CR40]). A decreasing trend in elevated serum lactate indicates that H~2~O~2~-induced Krebs cycle inhibition is being reversed as excess mitochondrial H~2~O~2~ is removed followed by restoration of mitochondrial proton motive force needed to transport pyruvate into the mitochondrial matrix. Decreasing cytosolic pyruvate will enhance the conversion of lactate to pyruvate (in the cytosol) and reduce diffusion of cellular lactate into the systemic circulation contributing to the reduction of serum lactate.

Restoration of vascular responsiveness by STS may cause extant vasoactive measures such as fluid loading or vasopressor therapy to have an unanticipated and deleterious augmented effect. Thus, STS should be administered in the appropriate IV fluids accompanied by continuous monitoring. Finally, if H~2~O~2~ reduction therapy proves to be successful in the treatment of sepsis, we should consider this type of therapy to restore depleted blood reducing equivalents with STS before blood H~2~O~2~ becomes toxically elevated in critically ill individuals.

Discussion {#Sec8}
==========

In each disease, SLE, UC and sepsis, the immune response plays a prominent role in pathophysiology. However, there is no evidence that the immune system is involved in the pathogenesis of these diseases. What starts the colitis in individuals with UC? Why does sepsis cause organ failure and hypotension? And why do individuals with SLE produce auto reactive antibodies against their own DNA? All of these observations can be explained by the multi-faceted effects of hydrogen peroxide.

Therapy aimed at the immune response in UC and SLE does not prevent life-long relapse. And all therapeutic attempts to modulate the immune response in sepsis have failed to improve survival in individuals with this condition. In contrast, hydrogen peroxide provides an evidence-based therapeutic and druggable target for each disease. Colonic mucosal hydrogen peroxide (a known colitic agent) is significantly elevated prior to the appearance of colitis in patients with UC, satisfying the temporal requirement for causality. Similarly, toxic levels of hydrogen peroxide have been reported in the blood of individuals with sepsis, and systemic hydrogen peroxide toxicity mirrors the laboratory and clinical abnormalities observed in patients with sepsis.

Likewise, the evidence strongly suggests a causal role for hydrogen peroxide in the systemic lymphocyte apoptosis observed in individuals SLE leading to auto-antigenic exposure and subsequent auto-antibody formation by the adaptive immune system.

In UC, reduction of colonic hydrogen peroxide led to complete mucosal healing in 85% of 36 patients with refractory disease. In a similar fashion, reduction of toxically elevated blood hydrogen peroxide in sepsis is anticipated to significantly reduce the high mortality and post-discharge morbidity caused by this condition. And based on data implicating a causal role for lymphocyte hydrogen peroxide in SLE, maintenance of normal cellular hydrogen peroxide levels is expected to prevent the apoptosis that leads to auto-antigenic exposure and relapse in this illness.

These three diseases represent the prototypical expression of impaired redox homeostasis leading to excess hydrogen peroxide production. Redox homeostasis is impaired on a cellular (lymphocyte, macrophage) level in SLE, on a tissue level (colonic epithelium) in UC, and in sepsis, redox homeostasis is systemically impaired. The end result of impaired redox homeostasis is a build-up of free (un-neutralized) cellular hydrogen peroxide, which can lead to a different patho-phenotype depending upon the location in the body where it accumulates. Impaired redox homeostasis may also be a causal factor in the pathogenesis of other diseases as well.

The healthcare cost savings that can be achieved by a common therapeutic platform for all three diseases are considerable. Sepsis affects 1.7 million Americans each year with an average inpatient healthcare cost of \$18,000 (Rhee et al. [@CR90]; Paoli et al. [@CR77]). Overall, one-sixth develop persistent physical disability or cognitive impairment with healthcare costs to individual patients and families of approximately \$50,000 annually (Prescott and Angus [@CR84]; Hajj et al. [@CR38]). This exceeds \$44 billion dollars annually for sepsis related healthcare. Annual total costs for the approximately one million individuals with UC are about \$12 billion dollars while mean total annual cost for the estimated 320,000 individuals with SLE in the United States is close to \$6.5 billion dollars (Pilon et al. [@CR78]; Gandhi et al. [@CR33]; Panopalis et al. [@CR76]). With total expenses for these three diseases exceeding \$60 billion dollars a year the beneficial economic ramifications of a common therapeutic approach are substantial.

Redox medicine is still in its infancy and there is much research and work to be done in order to fully understand the range of clinical manifestations of impaired redox homeostasis and its proper treatment. This applies to both oxidative and reductive stress as causal and contributory factors in the pathogenesis and pathophysiology of disease. Because of the continuous metabolic production of cellular hydrogen peroxide, redox homeostasis is intimately associated with cellular metabolism and bioenergetics, which in turn are influenced by genetic predisposition and environmental factors.

Thus, redox medicine can make a significant contribution to understanding how and why we develop disease on a personal and populational level, which can improve individual patient care and lead to new and effective public health initiatives. For example, the slow rise in auto-antibodies years prior to the development of clinical SLE suggests a progressive compromise in cellular redox homeostasis (decreased glutathione) during which time therapeutic intervention to restore redox homeostasis may prevent disease. Likewise, the knowledge that disease can be initiated by impaired redox homeostasis and elevated hydrogen peroxide suggests that the addition of reducing equivalents to the food supply may decrease the rising incidence of redox mediated disease.

Conclusion {#Sec9}
==========

Although immune activation is involved in the pathophysiology of sepsis, ulcerative colitis (UC) and systemic lupus erythematosus (SLE), there is no evidence that immune based mechanisms are responsible for the pathogenesis of these conditions. However, hydrogen peroxide can explain the development of each disease. Hydrogen peroxide is a unique molecule having diverse properties that can manifest as different diseases depending upon the site in the body that is exposed to excessive levels of this toxic metabolite. Hydrogen peroxide is a known colitic agent, and significantly elevated levels of this toxic metabolite have been documented to precede the appearance of colonic inflammation in individuals with ulcerative colitis. Similarly, significantly elevated levels of blood hydrogen peroxide have been reported in patients with sepsis and the systemic toxic effects of hydrogen peroxide mirror the clinical and laboratory abnormalities observed in this often-fatal condition. Finally, evidence suggests that hydrogen peroxide is responsible for enhanced lymphocyte apoptosis and impaired phagocytosis observed in SLE, which ultimately leads to auto-antigenic exposure and chronic immune activation. Although we are all expose to environmental oxidative stress, a subset of individuals is environmentally selected to develop disease as a result of a predisposing genetic makeup encoding for a diminished reductive capacity that facilitates the buildup of hydrogen peroxide in different parts of the body. In each case, the immune system is doing what its normally programmed to do given the circumstances it finds itself in.

The recognition of a causal role for hydrogen peroxide facilitates the rational design of therapeutic intervention based on a common mechanism of disease. The data indicate that in UC and SLE the immune reaction is in response to excess hydrogen peroxide in the colonic epithelium and lymphocytes respectively. This suggests that the appropriate therapy for treatment and long-term remission is reduction of hydrogen peroxide and replenishment of depleted reducing equivalents. Targeted therapy to reduce colonic hydrogen peroxide has shown to be highly effective in reversing colonic inflammation in patients with refractory UC. In a similar fashion, reduction of disease activity has been reported in patients with SLE receiving N-acetylcysteine, a precursor to glutathione, which has a critical role in the elimination cellular hydrogen peroxide in order to prevent hydrogen peroxide induced lymphocyte apoptosis, auto-antigenic exposure and subsequent immune activation. Short term immunosuppression has a role in active UC and SLE in order to mitigate the immune response however, there is no role for immunosuppression in sepsis because the immune system is already severely impaired due to profound lymphoid apoptosis as a result of systemic exposure to toxic levels of hydrogen peroxide. Reduction of elevated blood hydrogen peroxide levels is paramount in sepsis in order to prevent bioenergetic organ failure and hypotension, both of which are toxic effects of hydrogen peroxide exposure. Further studies are needed to explore this novel therapeutic mechanism.

H~2~O~2~

:   Hydrogen peroxide

UC

:   Ulcerative colitis

SLE

:   Systemic lupus erythematosus

STS

:   sodium thiosulfate
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